Expected earnings - XORTX Therapeutics Inc.
Source: US Earnings Reports
XORTX Therapeutics Inc. (XRTX) is expected to report for Q2 2025
XORTX Therapeutics Inc.
NASDAQ: XRTX
XRTX Trading
2.39% G/L:
$0.4505 Last:
5,346 Volume:
$0.4505 Open:
XRTX Latest News
March 05, 2026 07:00:00 am
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
February 04, 2026 06:00:00 pm
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
December 31, 2025 06:15:00 pm
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
XRTX Stock Data
$2,854,975
6,704,616
0.29%
8
N/A
Biotechnology & Life Sciences
Healthcare
CA
Calgary
